Lifetime burden of adverse health outcomes among women exposed in-utero to Diethylstilbestrol (DES).

Hoover, R.N., Hyer, M., Pfeiffer, R.M., Adam, E., Bond, B., Cheville, A.L., Colton, T., Hartge, P., Hatch, E.E., Herbst, A., Karlan, B.Y., Kaufman, R., Noller, K.L., Palmer, J.R., Robboy, S.J., Saal, R.C., Strohsnitter, W., Titus-Ernstoff, L., Troisi, R. N Engl J Med. 2011;365:1304-14.

Dr. Robert Hoover, Director of the Epidemiology and Biostatistics Program at the National Cancer Institute and a Principal Investigator on the DES Follow-up Study, conducted a comprehensive review of the health outcomes of daughters whose mothers were given DES during pregnancy. Click the following link to read about this important research.

** PubMed abstract for this article **